Scientific Highlights
Articles
Duarte-Silva, S.*, Da Silva, J. D.*, Monteiro-Fernandes, D.*, Costa, M. D., Neves-Carvalho, A., Raposo, M., Soares-Cunha, C., Correia, J. S., Nogueira-Goncalves, G., Fernandes, H. S., Oliveira, S., Ferreira-Fernandes, A. R., Rodrigues, F., Pereira-Sousa, J., Vilasboas-Campos, D., Guerreiro, S., Campos, J., Meireles-Costa, L., Rodrigues, C. M. P., Cabantous, S., Sousa, S. F., Lima, M., Teixeira-Castro, A., & Maciel, P. (2024). Glucocorticoid receptor-dependent therapeutic efficacy of tauroursodeoxycholic acid in preclinical models of spinocerebellar ataxia type 3. The Journal of Clinical Investigation, 134(5), e162246. https://doi.org/10.1172/JCI162246
Campos, A. B.*, Duarte-Silva, S.*, Fernandes, B., das Neves, S. P., Marques, F., Teixeira-Castro, A., Neves-Carvalho, A., Monteiro-Fernandes, D., Portugal, C. C., Socodato, R., Summavielle, T., Ambrósio, A. F., Relvas, J. B., & Maciel, P. (2022). Profiling Microglia in a Mouse Model of Machado-Joseph Disease. Biomedicines, 10(2), 237. https://doi.org/10.3390/biomedicines10020237
Rosa, A. I.*, Duarte-Silva, S.*, Silva-Fernandes, A., Nunes, M. J., Carvalho, A. N., Rodrigues, E., Gama, M. J., Rodrigues, C. M. P., Maciel, P., & Castro-Caldas, M. (2018). Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson’s Disease. Molecular Neurobiology, 55(12), 9139–9155. https://doi.org/10.1007/s12035-018-1062-4
Duarte-Silva, S., Neves-Carvalho, A., Soares-Cunha, C., Silva, J. M., Teixeira-Castro, A., Vieira, R., Silva-Fernandes, A., & Maciel, P. (2018). Neuroprotective Effects of Creatine in the CMVMJD135 Mouse Model of Spinocerebellar Ataxia Type 3. Movement Disorders: official journal of the Movement Disorder Society, 33(5), 815–826. https://doi.org/10.1002/mds.27292
Duarte-Silva, S., & Maciel, P. (2018). Pharmacological Therapies for Machado-Joseph Disease. Advances in Experimental Medicine and Biology, 1049, 369–394. https://doi.org/10.1007/978-3-319-71779-1_19
Duarte-Silva, S., Silva-Fernandes, A., Neves-Carvalho, A., Soares-Cunha, C., Teixeira-Castro, A., & Maciel, P. (2016). Combined therapy with m-TOR-dependent and -independent autophagy inducers causes neurotoxicity in a mouse model of Machado-Joseph disease. Neuroscience, 313, 162–173. https://doi.org/10.1016/j.neuroscience.2015.11.030
Duarte-Silva, S., Neves-Carvalho, A., Soares-Cunha, C., Teixeira-Castro, A., Oliveira, P., Silva-Fernandes, A., & Maciel, P. (2014). Lithium chloride therapy fails to improve motor function in a transgenic mouse model of Machado-Joseph disease. Cerebellum (London, England), 13(6), 713–727. https://doi.org/10.1007/s12311-014-0589-9
Silva-Fernandes, A.*, Duarte-Silva, S.*, Neves-Carvalho, A., Amorim, M., Soares-Cunha, C., Oliveira, P., Thirstrup, K., Teixeira-Castro, A., & Maciel, P. (2014). Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics, 11(2), 433–449. https://doi.org/10.1007/s13311-013-0255-9
Silva-Fernandes, A.*, Costa, M. do C.*, Duarte-Silva, S.*, Oliveira, P., Botelho, C. M., Martins, L., Mariz, J. A., Ferreira, T., Ribeiro, F., Correia-Neves, M., Costa, C., & Maciel, P. (2010). Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products. Neurobiology of Disease, 40(1), 163–176. https://doi.org/10.1016/j.nbd.2010.05.021
Funding and Awards
Pioneer Research award, National Ataxia Foundation, USA, 2022 – Co-Principal Investigator: Dissecting the mechanism of action of TUDCA as a therapeutic for SCA3
Seed Money research award, National Ataxia Foundation, United States (2020-2021) – Principal investigator: Studying the effect of the molecular tweezer CLR01 in a mouse model of SCA3